Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
The Exchange has sought clarification from Bafna Pharmaceuticals Ltd on March 23 2026 with reference to significant movement in price in order to ens...more...
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results of the Compa...more...
The company reported standalone net profit of Rs 1.84 crore for the quarter ended December 31 2025 as compared to Rs 0.95 crore in the same period la...more...
Bafna Pharmaceuticals Limited has submitted to the Exchange the outcome of the Board Meeting held on February 11 2026 along with the Unaudit...more...
The Board of Directors of the Company in their Meeting held on February 11 2026 has inter-alia considered and approved the Un-Audited Financial Resul...more...
The Board of Directors of the Company in the Meeting held on February 11 2026 has inter-alia considered and approved the Unaudited Financial...more...
Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider...more...
Bafna Pharmaceuticals Limited has informed the Exchange about revision in Outlook of the Credit Ratings assigned to the Bank loan facilites ...more...
We hereby inform you that the Outlook of the Credit Ratings assigned to the Bank loan facilites of the Company has been revised by ICRA Limited.more...
As of December 2025 75.00% is owned by Indian Promoters and 25.00% by Public. Top five Promoters holding highest number of shares of Bafna P...more...
Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018 for the Quarter...more...
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended December 31 2025.more...
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula...more...
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of the extract of the Unaudited Financial Result...more...
The company reported standalone net profit of Rs 3.12 crore for the quarter ended September 30 2025 as compared to Rs 2.62 crore in the same period l...more...
Bafna Pharmaceuticals Limited has submitted to the Exchange the outcome of the Board Meeting held on November 11 2025 along with the Unaudit...more...
The Board of Directors of the Company in the Meeting held on November 11 2025 has inter-alia considered and approved the Unaudited Financial Results ...more...
The Board of Directors of the Compant in the meeting held on November 11 2025 has inter-alia considered and approved the Unaudited Financial...more...
Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider...more...
As of September 2025 75.00% is owned by Indian Promoters and 25.00% by Public. Top five Promoters holding highest number of shares of Bafna ...more...
BOARD MEETINGS Company Name : Supha Pharmachem Date : 30-03-2026